Skip to content
Neuropediatoolkit

Neuropediatoolkit

  • Toolkit
  • Clinical guidelines
  • School
  • Archive
  • About

PTEN.

Posted byAlberto Alcantud 11 de September de 202212 de September de 2022

Fundación PHTS.

Posted byAlberto Alcantud11 de September de 202212 de September de 2022Posted inRiesgo oncológico

Post navigation

Previous post Previous post:
Neurofibromatosis tipo 1.
Next post Next post:
Trastornos neurogenéticos y riesgo oncológico.
Neuropediatoolkit, Proudly powered by WordPress.
English
Spanish